| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |